Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Organic Pores in the Gufeng and Longmaxi Formation Shale, Sichuan Basin: Combined Effects of Bioprecursor, Pore Filling, and Mineral-Organic Interactions.

ACS omega·2026
Same author

Fusobacterium varium Exacerbates Neutrophil-driven Intestinal Inflammation Associated with Succinate-SUCNR1-NF-κB Signaling.

Inflammation·2026
Same author

Prospective analysis of long-term trajectories of functional scores before and after a diagnosis of stroke.

Communications medicine·2026
Same author

Qingfei Tongluo Formula attenuates COPD-associated ferroptosis by restoring arachidonic acid metabolic balance via dual inhibition of prostaglandin-endoperoxide synthase 2 and soluble epoxide hydrolase 2.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

OTUD5-TIF1γ-SMAD3/4 positive feedback loop inhibits TGF-β-induced EMT and metastasis in NSCLC.

Cell death & disease·2026
Same author

Programmable Circular Single-Stranded DNA Acts as Recyclable Anti-miRNA Nucleotides to Inhibit Colorectal Cancer.

Small methods·2026
Same journal

Visual disability accommodations and ophthalmology.

BMJ open ophthalmology·2026
Same journal

Safety and efficacy of biosimilar aflibercept MYL-1701P in diabetic macular oedema: 20-week extension results following the INSIGHT pivotal trial.

BMJ open ophthalmology·2026
Same journal

Clinical efficacy of portable, cost-effective manual thermal pulsation for obstructive meibomian gland dysfunction and factors associated with therapeutic efficacy.

BMJ open ophthalmology·2026
Same journal

Long-term axial elongation in myopic children wearing DIMS spectacle lenses: an 8-to-10-year observational study.

BMJ open ophthalmology·2026
Same journal

A systematic review of neuroprotective therapies for visual acuity preservation in retinitis pigmentosa.

BMJ open ophthalmology·2026
Same journal

Alternative posology for brolucizumab: a 6-week loading regimen is as effective as a 4-week regimen for the treatment of nAMD.

BMJ open ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.3K

Network-based hub biomarker discovery for glaucoma.

Min Li1, Shunming Liu2, Shuo Ma3,4

  • 1Medical Research Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China.

BMJ Open Ophthalmology
|November 13, 2024
PubMed
Summary
This summary is machine-generated.

This study identified 10 key biomarkers and drug targets for glaucoma, aiding early diagnosis and treatment. These findings, verified by genetic and epidemiological data, offer new hope for managing this leading cause of irreversible blindness.

Keywords:
Glaucoma

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

2.3K

Related Experiment Videos

Last Updated: May 6, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.3K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

2.3K

Area of Science:

  • Ophthalmology
  • Genetics
  • Bioinformatics

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Early detection is challenging due to asymptomatic progression.
  • Identifying reliable biomarkers for early diagnosis and treatment is critical.

Purpose of the Study:

  • To identify hub biomarkers and drug targets for glaucoma using a network-based approach.
  • To validate these findings using genomic and epidemiological data.
  • To explore potential new applications for diagnosing and treating glaucoma.

Main Methods:

  • Construction of human disease-biomarker and disease-target-drug interaction networks using multiomics data.
  • Application of a greedy search algorithm to identify hub biomarkers and drug targets.
  • Validation using UK Biobank genome-wide association studies and epidemiological data.
  • Biological network and functional analysis to identify common pathways.

Main Results:

  • Identification of 10 hub biomarkers/drug targets for glaucoma diagnosis, treatment, and prognosis.
  • Verification of results through text mining and genomic/epidemiological data.
  • Prediction of novel diagnostic applications for BMP1 and MMP9.
  • Discovery of pivotal pathways associated with identified hub biomolecules.

Conclusions:

  • A network-based approach successfully identified key diagnostic and therapeutic biomarkers for glaucoma.
  • Verified hub biomarkers show significant potential for improving glaucoma diagnosis and treatment.
  • Identified relationships between glaucoma and associated diseases provide a foundation for future research.